ArticleiScience2025
Comparative efficacy and safety of therapeutic strategies for EGFRvIII positive recurrent glioblastoma.
Jinming Qiu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it